Based on this, a study from Kerala was carried-out to screen for differences in the RD1 region.
The range of international PPD prevalence rates may be due to cross-cultural variables, screening methods, differences in the perception of mental health and its stigma, or differences in socio-economic backgrounds [ 12].
To screen for differences in the growth of cells in the presence or the absence of cytokines in 2D and 3D conditions, a flow cytometry analysis of cells recovered after 7 days of culture was performed.
Different genotypes of G.herbaceum were screened for apparent differences in the root growth under control and osmotic stress conditions.
30 The CD-3 is a nondestructive handheld battery-powered tool that uses multiple light sources to screen for differences in reflectance from the surfaces of dosage forms and their packaging.
This pattern of presentation may be partially explained by the influence of screening programmes and differences in the use of diagnostic ultrasound in paediatric primary care in other European countries and may, to some extent, explain the lower survival in Great Britain during 1988–1995.
To explore the possibility that differences in diabetes screening intensity might explain differences in the rate of progression to cardiovascular complications after diagnosis, we compared between ethnic groups the number of glucose and HbA1c tests performed for each patient in the 2-year period before diabetes diagnosis.
31 Although Fukao et al. 32 reported differences in family history and smoking between participants and non‐participants in gastric cancer screening, the difference in the backgrounds between the endoscopic and radiographic screening groups is unclear.
We suggest that surveillance practices (a gynaecology consultation or a mammography during the years before diagnosis) as well as the circumstances of the mammography (screening or not) resulting from differences in the screening programmes in the counties may have influenced the stage at diagnosis.
If screening rates in other OECD countries are consistent with their own screening recommendations, then understanding cross-country differences in the timing of screening initiation and termination between the U.S. and other countries can potentially aid in interpreting comparisons of cancer incidence and survival statistics.
